Randomized study of high-dose chemotherapy plus rituximab (R-HDS) vs conventional chemotherapy with rituximab (R-FC) in chronic lymphocytic leukemia at high risk.
Phase of Trial: Phase III
Latest Information Update: 24 May 2014
At a glance
- Drugs Rituximab (Primary) ; Antineoplastics; Cyclophosphamide; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 25 May 2011 New trial record